市场调查报告书
商品编码
1540957
2024-2032 年按设备技术、应用、最终用户和地区分類的消融设备市场报告Ablation Devices Market Report by Device Technology, Application, End User, and Region 2024-2032 |
IMARC Group年全球消融器械市场规模达59亿美元。危及生命的疾病的日益流行、电生理学去除异常组织的广泛采用,以及带有机器人导航系统的下一代消融设备的开发,是推动市场发展的一些关键因素。
消融装置是在各种医疗程序中用于移除或破坏组织的医疗器械或工具,通常目的是治疗或控制某些医疗状况。这些设备的工作原理是将热、冷或射频等能量传递到目标组织,导致其被去除或改变。消融手术是微创手术,通常比传统手术方法更受欢迎,因为它们通常可以减轻疼痛、缩短恢復时间并降低併发症的风险。
该市场正在经历由几个关键因素推动的成长,包括癌症、心房颤动和慢性静脉功能不全(CVI)等危及生命的疾病的盛行率不断增加。疾病发生率的上升凸显了对有效消融手术的需求。此外,大众对微创消融技术可用性的认识不断增强,正在推动市场扩张。这些手术具有许多优点,包括减轻疼痛、最小化疤痕、减少不适以及加速患者康復时间。此外,透过移除异常组织来解决不规则心律和心律不整的电生理学程序的广泛采用对市场成长做出了重大贡献。此外,製造商还透过製造非热、非肿胀和非硬化的静脉内消融装置来满足不断变化的医疗需求,这些装置专为有效治疗浅静脉逆流而设计。
危及生命的疾病的盛行率不断增加
癌症仍然是全世界死亡的主要原因之一,近年来发病率不断上升。消融手术,特别是在肿瘤学领域,作为手术的微创替代方案而受到重视。它们被用来破坏各种器官中的癌组织,例如肝臟、肾臟和肺臟。此外,CVI 是一种腿部静脉无法将血液充分返回心臟的疾病,导致疼痛、肿胀和皮肤变化。静脉内消融手术现在通常用于透过封闭故障静脉来治疗 CVI。 CVI 发病率的上升通常与生活方式因素和衰老有关,这推动了对用于静脉治疗的消融设备的需求。
电生理学的广泛采用
电生理学是心臟病学的一个分支,研究心臟的电活动。由于其在诊断和治疗包括心房颤动在内的各种心律不整方面的有效性,它的采用率激增。电生理学引导的消融手术涉及精确定位和消除心臟中异常电信号的来源。这种方法已成为许多心律不整的护理标准,为患者提供缓解症状和提高生活品质的机会。此外,随着医疗保健专业人员越来越认识到电生理引导消融的好处,其采用已经广泛,导致对相关消融装置和设备的需求不断增长。
下一代消融设备与机器人导航系统的集成
消融设备领域的技术进步是一个重要的驱动力。下一代消融设备采用机器人导航系统,可提高精确度、准确度和手术结果。机器人辅助消融可以实现更受控和更有针对性的组织消融,降低併发症的风险并改善患者的治疗效果。这些机器人系统提供治疗区域的即时成像和绘图,使医疗保健提供者能够更有信心地导航复杂的解剖结构。因此,这些先进消融设备的采用正在增加,特别是在寻求提供最先进治疗选择的医疗机构中。提高病人安全性和手术成功率的承诺进一步刺激了对这些设备的需求。
The global ablation devices market size reached US$ 5.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.4 Billion by 2032, exhibiting a growth rate (CAGR) of 10.2% during 2024-2032. The increasing prevalence of life-threatening diseases, the widespread adoption of electrophysiology to remove abnormal tissues, and the development of next-generation ablation devices with robotic navigation systems represent some of the key factors driving the market.
Ablation devices are medical instruments or tools used in various medical procedures to remove or destroy tissue, typically with the goal of treating or managing certain medical conditions. These devices work by delivering energy, such as heat, cold, or radiofrequency, to the targeted tissue, causing its removal or alteration. Ablation procedures are minimally invasive and are often preferred over traditional surgical methods because they typically result in less pain, shorter recovery times, and reduced risk of complications.
The market is experiencing growth driven by several key factors, including the increasing prevalence of life-threatening diseases such as cancer, atrial fibrillation, and chronic venous insufficiency (CVI). This rise in disease incidence underscores the demand for effective ablation procedures. Furthermore, the growing awareness among the public about the availability of minimally invasive ablation techniques is propelling market expansion. These procedures offer numerous advantages, including reduced pain, minimal scarring, decreased discomfort, and quicker patient recovery times. Additionally, the widespread adoption of electrophysiology procedures to address irregular heart rhythms and cardiac arrhythmia by removing abnormal tissues is contributing significantly to market growth. Besides, manufacturers are also responding to evolving medical needs by creating non-thermal, non-tumescent, and non-sclerosant endovenous ablation devices tailored for the effective treatment of superficial vein reflux.
Increasing prevalence of life-threatening diseases
Cancer remains one of the leading causes of death worldwide, with a rising incidence in recent years. Ablation procedures, particularly in oncology, have gained prominence as minimally invasive alternatives to surgery. They are employed to destroy cancerous tissues in various organs, such as the liver, kidney, and lung. Moreover, CVI is a condition where veins in the legs fail to adequately return blood to the heart, leading to pain, swelling, and skin changes. Endovenous ablation procedures are now commonly used to treat CVI by closing off malfunctioning veins. The rising incidence of CVI, often associated with lifestyle factors and aging, has driven the demand for ablation devices designed for venous treatments.
Widespread adoption of electrophysiology
Electrophysiology is a branch of cardiology that deals with the electrical activity of the heart. It has witnessed a surge in adoption due to its effectiveness in diagnosing and treating various cardiac arrhythmias, including atrial fibrillation. Electrophysiology-guided ablation procedures involve precisely locating and eliminating the source of abnormal electrical signals in the heart. This approach has become the standard of care for many heart rhythm disorders, offering patients a chance for symptom relief and improved quality of life. Moreover, with healthcare professionals increasingly recognizing the benefits of electrophysiology-guided ablation, its adoption has become widespread, leading to a growing demand for related ablation devices and equipment.
Integration of next-generation ablation devices with robotic navigation systems
The advancement of technology in the field of ablation devices is a significant driving force. Next-generation ablation devices incorporate robotic navigation systems, which enhance precision, accuracy, and procedural outcomes. Robotic-assisted ablation allows for more controlled and targeted tissue ablation, reducing the risk of complications and improving patient outcomes. These robotic systems provide real-time imaging and mapping of the treatment area, enabling healthcare providers to navigate complex anatomical structures with greater confidence. As a result, the adoption of these advanced ablation devices is on the rise, particularly among healthcare facilities looking to offer state-of-the-art treatment options. The promise of improved patient safety and procedural success rates further fuels the demand for these devices.
IMARC Group provides an analysis of the key trends in each segment of the global ablation devices market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on device technology, application and end user.
Radiofrequency Devices
Laser/Light Ablation
Ultrasound Devices
Cryoablation Devices
Others
Radiofrequency devices represent the most used device technology
The report has provided a detailed breakup and analysis of the market based on the device technology. This includes radiofrequency devices, laser/light ablation, ultrasound devices, cryoablation devices, and others. According to the report, radiofrequency devices represented the largest segment.
RF ablation has demonstrated effectiveness across a wide range of medical applications. It is used to treat conditions such as cardiac arrhythmias (e.g., atrial fibrillation), liver tumors, kidney tumors, and chronic pain management. This versatility makes RF technology a go-to choice for physicians dealing with various medical specialties. Moreover, RF ablation has a long history of safe and successful use in medical procedures. The technology has been refined over the years, and clinicians have extensive experience with its application. This track record of safety and efficacy instills confidence in both healthcare providers and patients.
Cancer Treatment
Cardiovascular Disease Treatment
Ophthalmologic Treatment
Gynecological Treatment
Urological Treatment
Cosmetic Surgery
Others
Cancer treatment holds the largest market share
A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes cancer treatment, cardiovascular disease treatment, ophthalmologic treatment, gynecological treatment, urological treatment, cosmetic surgery, and others. According to the report, cancer treatment represented the largest segment.
Cancer is a widespread and prevalent disease that affects millions of people globally. It can occur in various organs and tissues, leading to a high demand for effective treatment options. As the incidence of cancer continues to rise due to factors like aging populations and lifestyle changes, the need for cancer treatment methods, including ablation, remains significant. Moreover, ablation techniques have proven to be versatile in the field of oncology. These procedures can be used to treat both primary tumors and metastatic lesions, making them applicable across different stages and types of cancer. Ablation can be employed in various organs, such as the liver, kidney, lung, and bone, providing clinicians with a wide range of treatment options.
Hospitals
Ambulatory Surgical Centers
Others
Hospitals accounts for majority of market share
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.
Ablation procedures often require specialized equipment and trained medical professionals. Hospitals are well-equipped to handle complex medical interventions and have the necessary infrastructure, including operating rooms, imaging technology, and support staff, to perform these procedures safely and effectively. This makes hospitals the natural choice for patients seeking ablation treatments. Moreover, hospitals house a wide range of medical specialties, including cardiology, oncology, gastroenterology, urology, and more. Ablation devices are used across multiple medical disciplines to treat various conditions. Hospitals can offer a comprehensive suite of ablation services, making them a one-stop destination for patients with diverse medical needs.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, particularly the United States and Canada, boasts a highly developed and advanced healthcare infrastructure. The region is home to world-renowned medical institutions, hospitals, and research centers. This advanced infrastructure provides a solid foundation for the adoption of cutting-edge medical technologies, including ablation devices. Moreover, the region has one of the highest healthcare expenditure rates in the world. This substantial investment in healthcare, both by governments and private entities, enables the procurement of state-of-the-art medical equipment, including ablation devices. It also supports research and development efforts in the healthcare sector, leading to innovation and product advancements.
The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are allocating significant resources to research and development efforts to develop innovative and technologically advanced ablation devices. This includes the development of next-generation ablation systems with enhanced precision, safety features, and user-friendly interfaces. They are also expanding their product portfolios to offer a comprehensive range of ablation devices catering to various medical specialties and applications. This includes devices designed for cardiac ablation, oncology, pain management, gynecology, and more. Moreover, companies are expanding their reach into new geographical markets. This expansion involves obtaining regulatory approvals and certifications in different regions, establishing distribution networks, and adapting their products to meet specific regional requirements.
Abbott Laboratories
AngioDynamics Inc.
AtriCure Inc.
Boston Scientific Corporation
CONMED Corporation
Elekta AB (publ)
Johnson & Johnson
Medtronic plc
Olympus Corporation
Smith & Nephew plc
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Abbott has made notable developments in the field of ablation devices. They have introduced the EnSite Precision(TM) cardiac mapping system, which offers high-resolution imaging and accurate mapping of the heart. This technology enables precise identification of abnormal tissue during ablation procedures, improving the success rate of the treatment.
Johnson & Johnson has been actively involved in the development of innovative ablation technologies. It has introduced the TactiCath Contact Force Ablation Catheter, which provides real-time feedback on the amount of force applied during cardiac ablation procedures. This helps in achieving better outcomes and reducing the risk of complications.
Medtronic Plc have introduced the Arctic Front Advance Cryoballoon System, which is used for the treatment of atrial fibrillation. This system offers improved efficiency and precision in cardiac ablation procedures.